| Identification | Back Directory | [Name]
N4-(2,3-Dimethyl-2H-indazol-6-yl)-N4-methyl-2,4-pyrimidinediamine | [CAS]
1821666-71-0 | [Synonyms]
Pazopanib Impurity 43
N4-(2,3-Dimethyl-2H-indazol-6-yl)-N4-methyl-2,4-pyrimidinediamine
2,4-Pyrimidinediamine, N4-(2,3-dimethyl-2H-indazol-6-yl)-N4-methyl- | [Molecular Formula]
C14H16N6 | [MOL File]
1821666-71-0.mol | [Molecular Weight]
268.32 |
| Chemical Properties | Back Directory | [Boiling point ]
553.5±58.0 °C(Predicted) | [density ]
1.32±0.1 g/cm3(Predicted) | [solubility ]
DMSO (Slightly, Heated), Methanol (Slightly) | [form ]
Solid | [pka]
6.48±0.10(Predicted) | [color ]
White to Light Yellow |
| Hazard Information | Back Directory | [Uses]
N4-??(2,??3-??Dimethyl-??2H-??indazol-??6-??yl)??-??N4-??methyl-2,??4-??pyrimidinediamine is a degredation product of Pazopanib (P210925), an oral angiogenesis inhibitor targeting VEGFR and PDGFR. |
|
|